日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NIR-II biomimetic nanoplatform optogenetic CD274 editing of HNSCC immunogenicity for enhanced photoimmunotherapy

利用近红外二区仿生纳米平台进行光遗传学CD274编辑,增强头颈部鳞状细胞癌的免疫原性,从而提高光免疫疗法的疗效。

Chen, Yang; Liu, Longcai; Hu, Xiaojuan; Huang, Yilin; Yao, Shijie; Ji, Lichen; Zou, Hai; Mou, Xiaozhou; Cai, Yu

PD-L1/CD274 and miR-155/MIR155HG Genetic Variants as Prognostic and Risk Biomarkers in Diffuse Large B-Cell Lymphoma

PD-L1/CD274 和 miR-155/MIR155HG 基因变异作为弥漫性大B细胞淋巴瘤的预后和风险生物标志物

Elez, Marija; Misic, Debora; Velikic, Gordana; Karajovic, Jelena; Atanaskovic, Lavinika; Supic, Gordana

A comprehensive analysis of immune checkpoint receptor-ligand pairs in aortic diseases highlights the immunosuppressive roles of CD155 and CD274

对主动脉疾病中免疫检查点受体-配体对的全面分析突显了CD155和CD274的免疫抑制作用。

Shao, Ying; Saaoud, Fatma; Xu, Keman; Lu, Yifan; Wu, Sheng; Martinez, Laisel; Vazquez-Padron, Roberto; Kosmider, Beata; Wang, Hong; Yang, Xiaofeng

Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity

黄芩苷通过与CD274/PD-L1结合,促进自噬降解,从而增强抗肿瘤免疫力。

Bingjie Hao ,Shumeng Lin ,Haipeng Liu ,Junfang Xu ,Li Chen ,Tiansheng Zheng ,Wen Zhang ,Yifang Dang ,Russel J Reiter ,Chaoqun Li ,Hong Zhai ,Qing Xia ,Lihong Fan

Tumorous cholesterol biosynthesis curtails anti-tumor immunity by preventing MTOR-TFEB-mediated lysosomal degradation of CD274/PD-L1.

肿瘤胆固醇生物合成通过阻止 MTOR-TFEB 介导的 CD274/PD-L1 溶酶体降解来抑制抗肿瘤免疫。

Wang Huina, Yi Xiuli, Qu Di, Wang Xiangxu, Wang Hao, Zhang Hengxiang, Yang Yuqi, Gao Tianwen, Guo Weinan, Li Chunying

Correction: Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

更正:MSL复合物对CD274/PD-L1的表观遗传激活作用,使其作用超越了剂量补偿的范畴。

Wen, Aiping; Feng, Xuanfei; Li, Yingying; Cui, Xueli; Zou, Qixian; Cai, Yong; Jin, Jingji; He, Yunxiao

Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

MSL复合物对CD274/PD-L1的表观遗传激活,使其作用超越了剂量补偿的范畴。

Aiping Wen,Xuanfei Feng,Yingying Li,Xueli Cui,Qixian Zou,Yong Cai,Jingji Jin,Yunxiao He

CD274 (PD-L1) Polymorphisms as Predictors of Efficacy in First-Line Platinum-Based Chemotherapy for Extensive-Stage Small Cell Lung Cancer

CD274 (PD-L1) 多态性作为广泛期小细胞肺癌一线铂类化疗疗效的预测因子

Barba, Andrés; López-Vilaró, Laura; Ferre, Malena; Martinez-Recio, Sergio; Majem, Margarita; Sullivan, Ivana; Salazar, Juliana

CD274/PD-L1 copy number gained malignant peripheral nerve sheath tumor: A case report and literature review

CD274/PD-L1拷贝数增加的恶性周围神经鞘瘤:病例报告及文献综述

Na, Kiyong; Kim, Hong Jun

An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

骨髓中的IL-4信号通路驱动促肿瘤髓系造血

Nelson M LaMarche ,Samarth Hegde # ,Matthew D Park # ,Barbara B Maier ,Leanna Troncoso ,Jessica Le Berichel ,Pauline Hamon ,Meriem Belabed ,Raphaël Mattiuz ,Clotilde Hennequin ,Theodore Chin ,Amanda M Reid ,Iván Reyes-Torres ,Erika Nemeth ,Ruiyuan Zhang ,Oakley C Olson ,Deborah B Doroshow ,Nicholas C Rohs ,Jorge E Gomez ,Rajwanth Veluswamy ,Nicole Hall ,Nicholas Venturini ,Florent Ginhoux ,Zhaoyuan Liu ,Mark Buckup ,Igor Figueiredo ,Vladimir Roudko ,Kensuke Miyake ,Hajime Karasuyama ,Edgar Gonzalez-Kozlova ,Sacha Gnjatic ,Emmanuelle Passegué ,Seunghee Kim-Schulze ,Brian D Brown ,Fred R Hirsch ,Brian S Kim ,Thomas U Marron ,Miriam Merad